CORC

浏览/检索结果: 共32条,第1-10条 帮助

已选(0)清除 条数/页:   排序方式:
Impact of clinical and molecular features on efficacy and outcome of patients with non-small cell lung cancer receiving second-line osimertinib 期刊论文
BMC CANCER, 2022, 卷号: 22
作者:  Jin, Ying;  Lin, Chen;  Shi, Xun;  He, Qiong;  Yan, Junrong
收藏  |  浏览/下载:20/0  |  提交时间:2022/12/23
LS-106, a novel EGFR inhibitor targeting C797S, exhibits antitumor activities both in vitro and in vivo 期刊论文
CANCER SCIENCE, 2021, 页码: 12
作者:  Liu, Yingqiang;  Lai, Mengzhen;  Li, Shan;  Wang, Yanan;  Feng, Fang
收藏  |  浏览/下载:62/0  |  提交时间:2022/01/18
The correlation between the abundance of EGFR T790M mutation and osimertinib response in advanced non-small cell lung cancer 期刊论文
TRANSLATIONAL CANCER RESEARCH, 2021, 卷号: 10
作者:  Pan, Guoqiang;  Chen, Kaiyan;  Yu, Xiaoqing;  Sheng, Jiamin;  Fan, Yun
收藏  |  浏览/下载:38/0  |  提交时间:2021/11/01
Biomimetic codelivery overcomes osimertinib-resistant NSCLC and brain metastasis via macrophage-mediated innate immunity 期刊论文
JOURNAL OF CONTROLLED RELEASE, 2021, 卷号: 329, 页码: 1249-1261
作者:  Zhao, Pengfei;  Zhang, Jiaxin;  Wu, Aihua;  Zhang, Meng;  Zhao, Yuge
收藏  |  浏览/下载:107/0  |  提交时间:2021/05/24
Thyroid receptor-interacting protein 13 and EGFR form a feedforward loop promoting glioblastoma growth 期刊论文
CANCER LETTERS, 2020, 卷号: 493
作者:  Hu, Lulu;  Shen, Dachuan;  Liang, Dapeng;  Shi, Ji;  Song, Chunyan
收藏  |  浏览/下载:58/0  |  提交时间:2020/11/30
Osimertinib successfully combats EGFR-negative glioblastoma cells by inhibiting the MAPK pathway 期刊论文
ACTA PHARMACOLOGICA SINICA, 2020
作者:  Chen, Cheng;  Cheng, Chuan-dong;  Wu, Hong;  Wang, Zuo-wei;  Wang, Li
收藏  |  浏览/下载:25/0  |  提交时间:2020/11/26
[Mechanism of MALAT1 induced osimertinib resistance in HCC827 lung cancer cells]. 期刊论文
Zhonghua zhong liu za zhi [Chinese journal of oncology], 2019, 卷号: 41, 期号: 4
作者:  Kang X H;  Gao Y Y;  Wang Y;  Cui Y H;  Zhao K L
收藏  |  浏览/下载:9/0  |  提交时间:2019/12/05
Cost-Effectiveness of Osimertinib in Treating Newly Diagnosed, Advanced EGFR-Mutation-Positive Non-Small Cell Lung Cancer 期刊论文
ONCOLOGIST, 2019, 卷号: 24, 期号: 3
作者:  Wu, Bin;  Gu, Xiaohua;  Zhang, Qiang;  Xie, Feng
收藏  |  浏览/下载:5/0  |  提交时间:2019/12/05
Degradation of MCL-1 by bufalin reverses acquired resistance to osimertinib in EGFR-mutant lung cancer 期刊论文
TOXICOLOGY AND APPLIED PHARMACOLOGY, 2019, 卷号: 379
作者:  Cao, Fei;  Gong, Ya-Bin;  Kang, Xiao-Hong;  Lu, Zhi-Hong;  Wang, Ying
收藏  |  浏览/下载:30/0  |  提交时间:2019/12/05
Osimertinib (AZD9291) increases radio-sensitivity in EGFR T790M non-small cell lung cancer 期刊论文
ONCOLOGY REPORTS, 2019, 卷号: 41, 期号: 1, 页码: 77-86
作者:  Wang, Nannan;  Wang, Linlin;  Meng, Xiangjiao;  Wang, Jia;  Zhu, Lifang
收藏  |  浏览/下载:23/0  |  提交时间:2019/12/11


©版权所有 ©2017 CSpace - Powered by CSpace